BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 7949478)

  • 1. Safety and effectiveness of an aggressive and individualized bath-PUVA regimen in the treatment of psoriasis.
    Calzavara-Pinton PG; Ortel B; Hönigsmann H; Zane C; De Panfilis G
    Dermatology; 1994; 189(3):256-9. PubMed ID: 7949478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bath-5-methoxypsoralen-UVA therapy for psoriasis.
    Calzavara-Pinton PG; Zane C; Carlino A; De Panfilis G
    J Am Acad Dermatol; 1997 Jun; 36(6 Pt 1):945-9. PubMed ID: 9204060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of psoriasis with polyethylene sheet bath PUVA.
    Streit V; Wiedow O; Christophers E
    J Am Acad Dermatol; 1996 Aug; 35(2 Pt 1):208-10. PubMed ID: 8708022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paired comparison of bathwater versus oral delivery of 8-methoxypsoralen in psoralen plus ultraviolet: A therapy for chronic palmoplantar psoriasis.
    Hofer A; Fink-Puches R; Kerl H; Quehenberger F; Wolf P
    Photodermatol Photoimmunol Photomed; 2006 Feb; 22(1):1-5. PubMed ID: 16436174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PUVA therapy for psoriasis: comparison of oral and bath-water delivery of 8-methoxypsoralen.
    Lowe NJ; Weingarten D; Bourget T; Moy LS
    J Am Acad Dermatol; 1986 May; 14(5 Pt 1):754-60. PubMed ID: 3711379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bath-water compared with oral delivery of 8-methoxypsoralen PUVA therapy for chronic plaque psoriasis.
    Collins P; Rogers S
    Br J Dermatol; 1992 Oct; 127(4):392-5. PubMed ID: 1419760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bath PUVA and psoriasis: is a milder treatment a worse treatment?
    Delrosso G; Bornacina C; Farinelli P; Bellinzona F; Leigheb G; Colombo E
    Dermatology; 2008; 216(3):191-3. PubMed ID: 18182808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer incidence among Finnish psoriasis patients treated with 8-methoxypsoralen bath PUVA.
    Hannuksela-Svahn A; Pukkala E; Koulu L; Jansén CT; Karvonen J
    J Am Acad Dermatol; 1999 May; 40(5 Pt 1):694-6. PubMed ID: 10321595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phototoxicity of new psoralen-containing gels and creams versus bath PUVA.
    Nimkulrat P; Leenutaphong V; Sudtim S
    J Med Assoc Thai; 2005 Oct; 88(10):1406-11. PubMed ID: 16519387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of bath psoralen plus ultraviolet A (PUVA) vs. system PUVA in psoriasis: a prospective, open, randomized, multicentre study.
    Berneburg M; Herzinger T; Rampf J; Hoetzenecker W; Guenova E; Meisner C; Maetzke J; Schaefer T; Eberlein B; Scharffetter-Kochanek K; Rocken M
    Br J Dermatol; 2013 Sep; 169(3):704-8. PubMed ID: 23772997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of bathwater and oral delivery of 8-methoxypsoralen in PUVA therapy for plaque psoriasis.
    Cooper EJ; Herd RM; Priestley GC; Hunter JA
    Clin Exp Dermatol; 2000 Mar; 25(2):111-4. PubMed ID: 10733632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized, double-blind comparison of 1 mg/L versus 5 mg/L methoxsalen bath-PUVA therapy for chronic plaque-type psoriasis.
    Vongthongsri R; Konschitzky R; Seeber A; Treitl C; Hönigsmann H; Tanew A
    J Am Acad Dermatol; 2006 Oct; 55(4):627-31. PubMed ID: 17010742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of chronic palmoplantar eczema with local bath-PUVA therapy.
    Schempp CM; Müller H; Czech W; Schöpf E; Simon JC
    J Am Acad Dermatol; 1997 May; 36(5 Pt 1):733-7. PubMed ID: 9146535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of 8-MOP aqueous bath and 8-MOP ethanolic lotion (Meladinine) in local PUVA therapy.
    Shephard SE; Schregenberger N; Dummer R; Panizzon RG
    Dermatology; 1998; 197(1):25-30. PubMed ID: 9693181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction of treatment frequency and UVA dose does not substantially compromise the antipsoriatic effect of oral psoralen-UVA.
    Legat FJ; Hofer A; Quehenberger F; Kahofer P; Kerl H; Wolf P
    J Am Acad Dermatol; 2004 Nov; 51(5):746-54. PubMed ID: 15523353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phototesting in bath-PUVA: marked reduction of 8-methoxypsoralen (8-MOP) activity within one hour after an 8-MOP bath.
    Schempp CM; Schöpf E; Simon JC
    Photodermatol Photoimmunol Photomed; 1996 Jun; 12(3):100-2. PubMed ID: 8956358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of trioxsalen bath and oral methoxsalen PUVA in psoriasis.
    Turjanmaa K; Salo H; Reunala T
    Acta Derm Venereol; 1985; 65(1):86-8. PubMed ID: 2578716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation between 8-methoxypsoralen bath-water concentration and photosensitivity in bath-PUVA treatment.
    Tanew A; Kipfelsperger T; Seeber A; Radakovic-Fijan S; Hönigsmann H
    J Am Acad Dermatol; 2001 Apr; 44(4):638-42. PubMed ID: 11260539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bath-PUVA therapy improves impaired resting regulatory T cells and increases activated regulatory T cells in psoriasis.
    Kubo R; Muramatsu S; Sagawa Y; Saito C; Kasuya S; Nishioka A; Nishida E; Yamazaki S; Morita A
    J Dermatol Sci; 2017 Apr; 86(1):46-53. PubMed ID: 28139335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carcinogenic risk of bath PUVA in comparison to oral PUVA therapy.
    Shephard SE; Panizzon RG
    Dermatology; 1999; 199(2):106-12. PubMed ID: 10559574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.